Citi Pharma Limited (PSX:CPHL)

Citi Pharma Revenue

Citi Pharma had revenue of 3.51B PKR in the quarter ending September 30, 2026, with 4.28% growth. This brings the company's total for the last twelve months to 14.22B, up 6.92% year-over-year. In the fiscal year ending June 30, 2026, Citi Pharma had annual revenue of 14.08B with 7.01% growth. That makes Citi Pharma the 27,785th largest company in the world by revenue and 182nd in Pakistan.

• Revenue (ttm): 14.22B
• Revenue Growth: +6.92%
• P/S Ratio: 1.01
• Revenue / Employee: 25.95M
• Employees: 548
• Market Cap: 14.41B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Pakistan 13.74B 96.7%
• Export 475.66M 3.3%

Fiscal year ended Jun 30, 2026 See the full Citi Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	14.08B	922.28M	7.01%
Jun 30, 2025	13.15B	744.28M	6.00%
Jun 30, 2024	12.41B	12.26M	0.10%
Jun 30, 2023	12.40B	2.62B	26.76%
Jun 30, 2022	9.78B	3.98B	68.75%

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error